Argentine Mendoza Provincial Legislator Proposes: Including E-cigarettes in the Scope of Indoor Smoking Bans

Aug.22.2025
Argentine Mendoza Provincial Legislator Proposes: Including E-cigarettes in the Scope of Indoor Smoking Bans
Argentinian legislator Sergio Márquez proposes bill to regulate e-cigarettes in Mendoza province, aiming to address legal gaps in existing regulations.

Key Points: 

·Legislative Proposal: Sergio Márquez, a lawmaker from Mendoza, Argentina, has introduced a bill aimed at addressing the regulatory gap for e-cigarettes. 

·Legal Background: National Law No. 26.687 in Argentina establishes smoke-free spaces, but does not mention e-cigarettes, resulting in a legal void. 

·Expert Views: Experts emphasize the health risks associated with e-cigarettes and call for increased education and prevention measures targeting young people. 

·Other Provinces: Provinces like Córdoba and Tucumán have already expanded their laws to include e-cigarettes in indoor smoking bans.

 


 

Argentinian Senator Sergio Márquez has introduced a bill aimed at establishing a regulatory and punitive framework for e-cigarettes in Mendoza province. The bill is currently under review by the legislative body's health committee.

 

We hope this issue can be resolved. These issues are a trigger: dentists, dental surgeons and internists have all warned of the seriousness of e-cigarettes, and I have found that e-cigarettes are becoming more and more common in schools," said Márquez. 

 

Civil law expert and legislative advisor Marcos Barrionuevo explained that the bill aims to amend Provincial Law No. 8382, which follows National Law No. 26687, and regulates the advertising, promotion, and distribution of traditional tobacco. "The law prohibits smoking in enclosed spaces, but does not mention e-cigarettes, whether they contain nicotine or not. Our bill expands this ban to protect public health, especially that of young people, and prevent environmental damage," he explained. 

 

In addition, the initiative proposes to include sanctions in the "Sanction Code" to prevent the sale of tobacco to minors, a behavior that has even been found at daytime shows and youth activities. 

 

In Argentina, National Law No. 26.687 establishes smoke-free spaces, including schools, public transportation and public places. The National Administration of Medicines, Food and Medical Technology (ANMAT) in Argentina prohibited the import, distribution, sale and promotion of e-cigarettes in 2011, a measure that was approved in 2016 and strengthened by national decree in 2023. However, the regulations did not specifically address indoor smoking, creating a legal vacuum currently present in Mendoza province and other provinces. 

 

Other jurisdictions, such as Cordoba and Tucuman, have expanded their legal scope to include e-cigarettes in indoor smoking bans to protect public health and the environment. Mendoza hopes to join this trend through Márquez's bill, which also considers updating the sanction procedures established by Decree No. 748 of 2013. 

 

The bill also aims to incorporate discussions on the use of e-cigarettes in schools in order to address this issue through education and prevention, educating young people about the risks and impacts of using e-cigarettes.

 

In Mendosa, the municipal authorities issued a decree in the summer of 2024 banning smoking and the use of e-cigarettes in public places.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Product | RELX Partners With UK E-Liquid Brand T-Juice for Prime Pro × Red Astaire Bundle in France
Product | RELX Partners With UK E-Liquid Brand T-Juice for Prime Pro × Red Astaire Bundle in France
RELX and UK e-liquid brand T-Juice have launched the Prime Pro × Red Astaire bundle in France, combining the RELX Prime Pro open-system pod device with T-Juice’s signature Red Astaire nicotine salt e-liquid. The collaboration retains the existing Prime Pro hardware platform while using an established flavor brand to create a complete open-system offering. The product appeared in French retail and distribution channels in August 2026 and represents a co-branded retail bundle rather than a new device launch.
Aug.27
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14